scholarly journals Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study

2014 ◽  
Vol 6 (2) ◽  
pp. 210-218 ◽  
Author(s):  
Nobuya Inagaki ◽  
Kazuoki Kondo ◽  
Toru Yoshinari ◽  
Hideki Kuki
Keyword(s):  
Type 2 Diabetes ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Oral Antihyperglycemic Drugs

scholarly journals Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study

2018 ◽  
Vol 9 (4) ◽  
pp. 1549-1567 ◽  
Author(s):  
Hisamitsu Ishihara ◽  
Susumu Yamaguchi ◽  
Ikko Nakao ◽  
Taishi Sakatani
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

2014 ◽  
Vol 5 (2) ◽  
pp. 415-433 ◽  
Author(s):  
Kohei Kaku ◽  
Hiroshi Maegawa ◽  
Yukio Tanizawa ◽  
Arihiro Kiyosue ◽  
Yumiko Ide ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document